Tredje Ap Fonden Organon & Co. Transaction History

Tredje Ap Fonden

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$16.59 - $23.77 $99,622 - $142,738	6,005 Added 6.68%	95,881 $1.66 Million
Q2 2023 Aug 11, 2023	BUY	$19.27 - $24.63 $286,660 - $366,395	14,876 Added 19.83%	89,876 $1.87 Million
Q1 2023 May 10, 2023	BUY	$21.42 - $32.08 $1.07 Million - $1.6 Million	50,000 Added 200.0%	75,000 $1.76 Million
Q4 2022 Feb 10, 2023	BUY	$23.31 - $28.61 $582,750 - $715,250	25,000 New	25,000 $698,000
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $750,678 - $934,480	-26,220 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $745,959 - $996,360	26,220 New	26,220 $793,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Tredje Ap Fonden with notifications on news.